Cell Source, Inc.

CLCS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K May 6, 2022
3 Apr 21, 2022
10-K Apr 15, 2022
NT 10-K Mar 31, 2022
8-K Mar 11, 2022
10-Q Nov 15, 2021
10-Q Aug 12, 2021
4 Aug 11, 2021
4 Jul 7, 2021
4 Jul 7, 2021
4 Jul 7, 2021
4 Jul 7, 2021
4 Jun 10, 2021
4 Jun 10, 2021
SC 13D Jun 10, 2021
4 Jun 10, 2021
4 Jun 10, 2021
10-Q May 17, 2021
SC 13D Apr 21, 2021 SC-13D
3 Apr 20, 2021 FORM 3
10-K Apr 15, 2021 FORM 10-K
8-K Apr 2, 2021 FORM 8-K
NT 10-K Mar 31, 2021 NT 10-K
SC 13G Dec 29, 2020 SC 13G
3 Dec 29, 2020 FORM 3
← Newer Page 2 of 6 · 139 filings Older →